Intermediate-risk endometrial cancer-adjuvant treatment

被引：4
作者：
Eifel, Patricia J. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2010年 / 7卷 / 10期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; RANDOMIZED-TRIAL; STAGE-I; CARCINOMA; ADENOCARCINOMA; RADIOTHERAPY; SURGERY; THERAPY;
D O I：
10.1038/nrclinonc.2010.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Adjuvant vaginal brachytherapy was compared with adjuvant pelvic radiation therapy in patients with high-intermediate-risk uterine cancers in the PORTEC-2 trial. The results suggest that vaginal brachytherapy is the treatment of choice; however, the inclusion of very few patients with grade 2 or 3 disease limits generalizability of the results to these subgroups.
引用
收藏
页码：553 / 554
页数：2
相关论文
共 9 条
  • [1] AALDERS J, 1980, OBSTET GYNECOL, V56, P419
  • [2] CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
  • [3] 2-8
  • [4] Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
    Creutzberg, CL
    van Putten, WLJ
    Koper, PCM
    Lybeert, MLM
    Jobsen, JJ
    Wárlám-Rodenhuis, CC
    De Winter, KAJ
    Lutgens, LCHW
    van den Bergh, ACM
    van de Steen-Banasik, E
    Beerman, H
    van Lent, M
    [J]. LANCET, 2000, 355 (9213) : 1404 - 1411
  • [5] ADENOCARCINOMA OF THE ENDOMETRIUM - ANALYSIS OF 256 CASES WITH CARCINOMA LIMITED TO THE UTERINE CORPUS - PATHOLOGY REVIEW AND ANALYSIS OF PROGNOSTIC VARIABLES
    HENDRICKSON, M
    ROSS, J
    EIFEL, PJ
    COX, RS
    MARTINEZ, A
    KEMPSON, R
    [J]. GYNECOLOGIC ONCOLOGY, 1982, 13 (03) : 373 - 392
  • [6] KADAR N, 1992, OBSTET GYNECOL, V80, P655
  • [7] A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
    Keys, HM
    Roberts, JA
    Brunetto, VL
    Zaino, RJ
    Spirtos, NM
    Bloss, JD
    Pearlman, A
    Maiman, MA
    Bell, JG
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 744 - 751
  • [8] RELATIONSHIP BETWEEN SURGICAL PATHOLOGICAL RISK-FACTORS AND OUTCOME IN CLINICAL STAGE-I AND STAGE-II CARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MORROW, CP
    BUNDY, BN
    KURMAN, RJ
    CREASMAN, WT
    HELLER, P
    HOMESLEY, HD
    GRAHAM, JE
    [J]. GYNECOLOGIC ONCOLOGY, 1991, 40 (01) : 55 - 65
  • [9] Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
    Nout, R. A.
    Smit, V. T. H. B. M.
    Putter, H.
    Juergenliemk-Schulz, I. M.
    Jobsen, J. J.
    Lutgens, L. C. H. W.
    van der Steen-Banasik, E. M.
    Mens, J. W. M.
    Slot, A.
    Kroese, M. C. Stenfert
    van Bunningen, B. N. F. M.
    Ansink, A. C.
    van Putten, W. L. J.
    Creutzberg, C. L.
    [J]. LANCET, 2010, 375 (9717) : 816 - 823
1